XML 19 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Fixed maturities available for sale, at amortized cost $ 16,629,621 $ 18,143,305
Short-term investments available for sale, at amortized cost 3,070,120 1,924,292
Allowance for credit losses on investments 2,111 2,397
Collateral received under securities lending, at amortized cost 0 301,089
Other investments measured at fair value 2,043,970 3,824,796
Securities pledged under securities lending, at amortized cost 0 294,493
Allowance for credit losses on premiums receivable 38,715 37,781
Allowance for credit losses on reinsurance recoverable 12,831 11,636
Allowance for credit losses on contractholder receivable $ 3,484 $ 8,638
Common shares, par value per share $ 0.0011 $ 0.0011
Common shares issued (shares) 582,908,723 579,000,841
Common shares held in treasury (shares) 195,650,971 172,280,199
Fixed maturities    
Allowance for credit losses on investments $ 2,111 $ 2,397
Short-term investments    
Short-term investments available for sale, at amortized cost 3,070,120 1,924,292
Allowance for credit losses on investments [1] $ 0 $ 0
[1] Effective January 1, 2020, the Company adopted ASU 2016-13 and as a result any credit impairment losses on the Company’s available-for-sale investments are recorded as an allowance, subject to reversal.